Healthcare -
Biotechnology - NASDAQ - US
$ 3.62
-3.21 %
$ 124 M
Market Cap
-1.37
P/E
TARA - CAPITAL EXPENDITURES
Capital Expenditures TARA - Protara Therapeutics, Inc.
-45 K
LAST VALUE
72.52%
2 YEAR CAGR
17.67%
5 YEAR CAGR
-16.23%
10 YEAR CAGR